| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| May 6, 2026 | Sell(S) | 8K | $28.04 | $238K | 358K |
| May 6, 2026 | Sell(S) | 2K | $29.07 | $60K | 356K |
| May 5, 2026 | Sell(S) | 10K | $28.12 | $279K | 368K |
| May 5, 2026 | Sell(S) | 968 | $29.00 | $28K | 367K |
| May 4, 2026 | Sell(S) | 5K | $27.36 | $131K | 388K |
| May 4, 2026 | Sell(S) | 9K | $28.28 | $254K | 379K |
| May 4, 2026 | Sell(S) | 325 | $29.56 | $10K | 379K |
| May 4, 2026 | Sell(S) | 787 | $30.12 | $24K | 378K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0002021256-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for MapLight Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.